within Pharmacolibrary.Drugs.ATC.A;

model A04AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 14.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0063,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dolasetron is a selective serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to prevent nausea and vomiting associated with chemotherapy, radiation, and surgery. It is currently approved for medical use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>Herndon, AK, et al., &amp; Gustafson, DL (2018). Preliminary pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in healthy cats. <i>Journal of feline medicine and surgery</i> 20(8) 721–727. DOI:<a href=&quot;https://doi.org/10.1177/1098612X17729310&quot;>10.1177/1098612X17729310</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28905667/&quot;>https://pubmed.ncbi.nlm.nih.gov/28905667</a></p></li><li><p>Dimmitt, DC, et al., &amp; Weir, SJ (1998). Pharmacokinetics of oral and intravenous dolasetron mesylate in patients with renal impairment. <i>Journal of clinical pharmacology</i> 38(9) 798–806. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9753207/&quot;>https://pubmed.ncbi.nlm.nih.gov/9753207</a></p></li><li><p>Dimmitt, DC, et al., &amp; Hahne, W (1998). Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylate. <i>The Annals of pharmacotherapy</i> 32(1) 39–44. DOI:<a href=&quot;https://doi.org/10.1345/aph.17134&quot;>10.1345/aph.17134</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9475818/&quot;>https://pubmed.ncbi.nlm.nih.gov/9475818</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A04AA04;
